IBT
MRK icon

International Biotechnology Trust’s Merck MRK Stock Holding History

International Biotechnology Trust’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-87,194
Closed -$6.4M – 57
2020
Q1 		$6.4M Buy
87,194
+210
+0.2% +$16.5K 2.92% 15
2019
Q4 		$7.55M Buy
+86,984
New +$7.14M 2.72% 14

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

International Biotechnology Trust's MRK Position: Q2 2020 in Review

International Biotechnology Trust sold out of Merck (MRK) in Q2 2020, closing a stake of 87,194 shares — an estimated $6.4M sold.

International Biotechnology Trust first reported a position in MRK in Q4 2019 and held it in 2 quarters. The position peaked at $7.55M in Q4 2019. 2,496 funds tracked by Wall St. Rank hold MRK as of Q2 2020.

  • International Biotechnology Trust reported no remaining Merck position as of Q2 2020 after selling out during the quarter.
  • International Biotechnology Trust sold 87,194 Merck shares in Q2 2020, an estimated $6.4M.
  • International Biotechnology Trust first reported a position in Merck in Q4 2019 and held it in 2 quarters.
  • International Biotechnology Trust's Merck position peaked at $7.55M in Q4 2019.
  • 2,496 funds tracked by Wall St. Rank held Merck as of Q2 2020.

Based on International Biotechnology Trust's 13F filing for Q2 2020, filed 14 Jul 2020.